465 related articles for article (PubMed ID: 28771191)
21. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.
Zehbe I; Mytilineos J; Wikström I; Henriksen R; Edler L; Tommasino M
Hum Immunol; 2003 May; 64(5):538-42. PubMed ID: 12691704
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.
Smeets SJ; Braakhuis BJ; Abbas S; Snijders PJ; Ylstra B; van de Wiel MA; Meijer GA; Leemans CR; Brakenhoff RH
Oncogene; 2006 Apr; 25(17):2558-64. PubMed ID: 16314836
[TBL] [Abstract][Full Text] [Related]
23. Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses.
Howley PM; Münger K; Romanczuk H; Scheffner M; Huibregtse JM
Princess Takamatsu Symp; 1991; 22():239-48. PubMed ID: 1668886
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer.
Morgan EL; Patterson MR; Ryder EL; Lee SY; Wasson CW; Harper KL; Li Y; Griffin S; Blair GE; Whitehouse A; Macdonald A
PLoS Pathog; 2020 Jun; 16(6):e1008624. PubMed ID: 32555725
[TBL] [Abstract][Full Text] [Related]
25. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.
DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD
Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744
[TBL] [Abstract][Full Text] [Related]
26. HPV DNA methylation in cervical and head and neck carcinomas.
A Mortaki A; S Mastronikolis N; Tsiambas E; I Pappa K; Ragos V
J BUON; 2018; 23(6):1929-1930. PubMed ID: 30610826
[No Abstract] [Full Text] [Related]
27. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
Ndiaye C; Mena M; Alemany L; Arbyn M; Castellsagué X; Laporte L; Bosch FX; de Sanjosé S; Trottier H
Lancet Oncol; 2014 Nov; 15(12):1319-31. PubMed ID: 25439690
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus and the landscape of secondary genetic alterations in oral cancers.
Gillison ML; Akagi K; Xiao W; Jiang B; Pickard RKL; Li J; Swanson BJ; Agrawal AD; Zucker M; Stache-Crain B; Emde AK; Geiger HM; Robine N; Coombes KR; Symer DE
Genome Res; 2019 Jan; 29(1):1-17. PubMed ID: 30563911
[TBL] [Abstract][Full Text] [Related]
29. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
30. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis.
Steenbergen RD; Ongenaert M; Snellenberg S; Trooskens G; van der Meide WF; Pandey D; Bloushtain-Qimron N; Polyak K; Meijer CJ; Snijders PJ; Van Criekinge W
J Pathol; 2013 Sep; 231(1):53-62. PubMed ID: 23674368
[TBL] [Abstract][Full Text] [Related]
31. Frequent genomic structural alterations at HPV insertion sites in cervical carcinoma.
Peter M; Stransky N; Couturier J; Hupé P; Barillot E; de Cremoux P; Cottu P; Radvanyi F; Sastre-Garau X
J Pathol; 2010 Jul; 221(3):320-30. PubMed ID: 20527025
[TBL] [Abstract][Full Text] [Related]
32. Biological and clinical aspects of HPV-related cancers.
Szymonowicz KA; Chen J
Cancer Biol Med; 2020 Nov; 17(4):864-878. PubMed ID: 33299640
[TBL] [Abstract][Full Text] [Related]
33. APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPV-Positive Head and Neck Squamous Cell Carcinoma.
Faden DL; Kuhs KAL; Lin M; Langenbucher A; Pinheiro M; Yeager M; Cullen M; Boland JF; Steinberg M; Bass S; Lewis JS; Lawrence MS; Ferris RL; Mirabello L
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452530
[TBL] [Abstract][Full Text] [Related]
34. Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma.
Rosty C; Sheffer M; Tsafrir D; Stransky N; Tsafrir I; Peter M; de Crémoux P; de La Rochefordière A; Salmon R; Dorval T; Thiery JP; Couturier J; Radvanyi F; Domany E; Sastre-Garau X
Oncogene; 2005 Oct; 24(47):7094-104. PubMed ID: 16007141
[TBL] [Abstract][Full Text] [Related]
35. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
36. HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence.
Speel EJ
Recent Results Cancer Res; 2017; 206():57-72. PubMed ID: 27699529
[TBL] [Abstract][Full Text] [Related]
37. The Role of E6 Spliced Isoforms (E6*) in Human Papillomavirus-Induced Carcinogenesis.
Olmedo-Nieva L; Muñoz-Bello JO; Contreras-Paredes A; Lizano M
Viruses; 2018 Jan; 10(1):. PubMed ID: 29346309
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatics analysis of immune characteristics in tumors with alternative carcinogenesis pathways induced by human papillomaviruses.
Smahel M; Nunvar J
Virol J; 2023 Dec; 20(1):287. PubMed ID: 38049810
[TBL] [Abstract][Full Text] [Related]
39. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA.
Penhallow J; Steingrimsdottir H; Elamin F; Warnakulasuriya S; Farzaneh F; Johnson N; Tavassoli M
Int J Oncol; 1998 Jan; 12(1):59-68. PubMed ID: 9454887
[TBL] [Abstract][Full Text] [Related]
40. Understanding the HPV integration and its progression to cervical cancer.
Oyervides-Muñoz MA; Pérez-Maya AA; Rodríguez-Gutiérrez HF; Gómez-Macias GS; Fajardo-Ramírez OR; Treviño V; Barrera-Saldaña HA; Garza-Rodríguez ML
Infect Genet Evol; 2018 Jul; 61():134-144. PubMed ID: 29518579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]